Selecteer de regio die het beste past bij je locatie of voorkeuren.
Deze instelling regelt de taal van de gebruikersinterface, inclusief knoppen, menu's en alle tekst op de site. Selecteer je voorkeurstaal voor de beste browse-ervaring.
Selecteer de talen voor vacatures die je wilt zien. Deze instelling bepaalt welke vacatures aan jou worden getoond.
The Laboratory for Thrombosis Research of KU Leuven (Campus Kulak Kortrijk) is looking for a dynamic and highly motivated PhD candidate, under supervision of Prof. Claudia Tersteeg. The PhD candidate will be part of the Laboratory for Thrombosis Research, which focuses on the molecular mechanisms by which key hemostatic cells and proteins such as platelets, von Willebrand factor and ADAMTS13 contribute to health and disease. The research combines fundamental science with translational approaches, including the development of preclinical animal models, novel treatment strategies and diagnostic assays.
Blood platelets are an essential component of a stable hemostatic plug. Their functions need to be finely tuned in order to prevent bleeding and avoid thrombotic events. At site of vascular lesion, a fraction of platelets loses their aggregatory properties and become procoagulant. These procoagulant activated platelets have been correlated with various clinical events. While their clinical relevance is increasingly recognized, the molecular mechanisms that drive the bifurcation between aggregating and procoagulant phenotypes remain unclear. This project will focus on unraveling novel pathways contributing to procoagulant platelet formation and understanding their function in (patho)physiological settings, by functionally validating candidate genes found using quantitative phosphoproteomics. This will be done using an innovative gene deletion strategy using Cas9-sgRNA in vivo. The results will deepen our understanding of the molecular basis of platelet heterogeneity and identify novel therapeutic targets to selectively modulate platelet function.
We seek an enthusiastic PhD candidate with a strong interest in molecular biology and biomedical sciences. Prior experience with gene editing is a plus.
The candidate is motivated to contribute to education within the bachelor's programs in biomedical sciences and medicine.
For more information, please contact Prof. Dr. Claudia Tersteeg, mail: [email protected].
KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.
KU Leuven is an autonomous university. It was founded in 1425. It was born of and has grown within the Catholic tradition.
De pagina van de werkgever bekijken